Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist with FDA-approved indications: Mounjaro for type 2 diabetes management and Zepbound for chronic weight management
Our health team at The HCG Institute is also ready to work with you on curating a weight management plan tailored to you
Effect of linagliptin monotherapy on glycaemic control and markers of beta-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial
They can also help you spot hidden calorie traps, like sugary drinks, creamy sauces, or processed snacks, that might slow your progress
persistent vomiting preventing fluid intake
Side Effects: Semaglutide: Common side effects include nausea, vomiting, and mild digestive issues
US$ 21.75
US$ 25.62
US$ 22.52
